2-(N-Methylamino)isobutyric acid | CAS:2566-34-9
2-(N-Methylamino)isobutyric acid
- 名称:2-(N-甲基氨基)异丁酸 | 2-(N-Methylamino)isobutyric acid
- CAS号:2566-34-9
- 别名:N-Methyl-2-amino-isobutyric acid; N-Methyl-2-methylalanine; N-Methyl-alpha-aminoisobutyric acid; alpha-(Methylamino)isobutyric acid
- 分子式:C5H11NO2
- 分子量:117.15
- EINESC号:219-898-2
产品描述
物理化学性质
熔点 | 272 ºC (sublm) (ethanol )** |
---|---|
沸点 | 192.5±23.0 ºC (760 Tor |
闪点 | 70.2±22.6 ºC, 计算值* |
密度 | 1.022±0.06 g/cm3 (20 º |
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Biocatalytic production of 5-hydroxy-2-adamantanone by P450cam coupled with NADH regeneration.Furuya T, et al. Journal of Molecular Catalysis. B, Enzymatic, 94, 111-118 (2013)
Application of shift reagents in the study of disubstituted derivatives of adamantane by NMR spectroscopy.Vodicka L, et al. Collection of Czechoslovak Chemical Communications, 40(1), 293-299 (1975)
[The effect of kemantane on T-helpers and T-suppressors].V M Man'ko et al.Zhurnal mikrobiologii, epidemiologii, i immunobiologii, (9)(9), 66-67 (1991-09-01)
Effect of adamantanone derivative possessing anti-HIV properties on the redox processes in the cytochrome P-450 system.I E Kovalev et al.Doklady. Biochemistry and biophysics, 378, 210-213 (2001-11-20)
[Interspecific differences in kemantan pharmacokinetics].S S Boĭko et al.Eksperimental'naia i klinicheskaia farmakologiia, 57(6), 48-50 (1994-11-01)
[Treatment of immunodeficient conditions caused by viral infection with the Soviet immunomodulator kemantan in patients with pulmonary tuberculosis].N V Kossii et al.Problemy tuberkuleza, (6)(6), 23-26 (1991-01-01)
An expeditious preparation of E-2-amino-5-hydroxyadamantane and its Z-isomer.Jaroskova L, et al. Tetrahedron Letters, 47(46), 8063-8067 (2006)
[Kemantane pharmacokinetics in rats].S S Boĭko et al.Biulleten' eksperimental'noi biologii i meditsiny, 110(11), 501-503 (1990-11-01)
[The mitostatic and lymphotoxic action of kemantane and its effect on B-suppressors].V M Man'ko et al.Zhurnal mikrobiologii, epidemiologii, i immunobiologii, (6)(6), 63-65 (1991-06-01)
Chemoselective hydrosilylation of hydroxyketones.Marta L Lage et al.Tetrahedron, 69(27-28), 5609-5613 (2013-09-03)
[The immunomodulator kemantan in the treatment of patients with exacerbated chronic obstructive bronchitis].E M Rekalova Likars'ka sprava, (4)(4), 73-76 (1992-04-01)
[The clinical pharmacokinetics of kemantane].S S Boĭko et al.Farmakologiia i toksikologiia, 54(1), 57-59 (1991-01-01)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!